DK2573166T3 - Fremgangsmåder til fremstilling af T-celler til celleterapi - Google Patents

Fremgangsmåder til fremstilling af T-celler til celleterapi Download PDF

Info

Publication number: DK2573166T3
Authority: DK; Denmark
Prior art keywords: cells; preparing; methods; cell therapy; therapy
Prior art date: 2004-02-26

Application number

DK12177732.0T

Other languages

English (en)

Inventor

Michael Har-Noy

Original Assignee

Immunovative Therapies Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-02-26

Filing date

2005-02-24

Publication date

2016-07-04

2005-02-24 Application filed by Immunovative Therapies Ltd filed Critical Immunovative Therapies Ltd

2016-07-04 Application granted granted Critical

2016-07-04 Publication of DK2573166T3 publication Critical patent/DK2573166T3/da

Links

210000001744 T-lymphocyte Anatomy 0.000 title 1
238000002659 cell therapy Methods 0.000 title 1
238000000034 method Methods 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0636—T lymphocytes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/515—Animal cells
- A61K2039/5154—Antigen presenting cells [APCs], e.g. dendritic cells or macrophages
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/23—Interleukins [IL]
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/40—Regulators of development
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/50—Cell markers; Cell surface determinants
- C12N2501/51—B7 molecules, e.g. CD80, CD86, CD28 (ligand), CD152 (ligand)
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/50—Cell markers; Cell surface determinants
- C12N2501/515—CD3, T-cell receptor complex
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/998—Proteins not provided for elsewhere
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2531/00—Microcarriers
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/30—Synthetic polymers
- C12N2533/40—Polyhydroxyacids, e.g. polymers of glycolic or lactic acid (PGA, PLA, PLGA); Bioresorbable polymers

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
Immunology (AREA)
Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
General Health & Medical Sciences (AREA)
Biomedical Technology (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
Genetics & Genomics (AREA)
Biotechnology (AREA)
General Engineering & Computer Science (AREA)
Biochemistry (AREA)
Cell Biology (AREA)
Microbiology (AREA)
Hematology (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Virology (AREA)
Transplantation (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Apparatus Associated With Microorganisms And Enzymes (AREA)
Peptides Or Proteins (AREA)
Medicinal Preparation (AREA)
Materials For Medical Uses (AREA)

DK12177732.0T 2004-02-26 2005-02-24 Fremgangsmåder til fremstilling af T-celler til celleterapi DK2573166T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US54796604P	2004-02-26	2004-02-26
EP05713988A EP1776583A4 (en)	2004-02-26	2005-02-24	PROCESSES FOR THE PREPARATION OF T CELLS FOR CELL THERAPY

Publications (1)

Publication Number	Publication Date
DK2573166T3 true DK2573166T3 (da)	2016-07-04

Family

ID=34910966

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK12177732.0T DK2573166T3 (da)	2004-02-26	2005-02-24	Fremgangsmåder til fremstilling af T-celler til celleterapi

Country Status (14)

Country	Link
US (6)	US7678572B2 (da)
EP (3)	EP3067415A1 (da)
JP (5)	JP2007525225A (da)
CA (1)	CA2555714C (da)
CY (1)	CY1117750T1 (da)
DK (1)	DK2573166T3 (da)
ES (1)	ES2586295T3 (da)
HU (1)	HUE028467T2 (da)
IL (1)	IL177404A (da)
LT (1)	LT2573166T (da)
PL (1)	PL2573166T3 (da)
PT (1)	PT2573166T (da)
SI (1)	SI2573166T1 (da)
WO (1)	WO2005081982A2 (da)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7435592B2 (en)	2003-05-13	2008-10-14	Immunovative Therapies, Ltd.	Compositions for allogeneic cell therapy
US7592431B2 (en) *	2004-02-26	2009-09-22	Immunovative Therapies, Ltd.	Biodegradable T-cell Activation device
SI2573166T1 (sl)	2004-02-26	2016-09-30	Immunovative Therapies, Ltd.	Metode za pripravo T-celic za celično terapijo
CA2530514C (en) *	2004-03-01	2017-01-31	Immunovative Therapies, Ltd.	Cell therapy formulation method and composition
US9320794B2 (en)	2006-11-13	2016-04-26	Immunovative Therapies, Ltd.	Ablative immunotherapy
US7972594B2 (en)	2006-11-13	2011-07-05	Immunovative Therapies Ltd.	Ablative immunotherapy
US9249423B2 (en)	2007-02-02	2016-02-02	Yale University	Method of de-differentiating and re-differentiating somatic cells using RNA
US10155038B2 (en)	2007-02-02	2018-12-18	Yale University	Cells prepared by transient transfection and methods of use thereof
US8859229B2 (en) *	2007-02-02	2014-10-14	Yale University	Transient transfection with RNA
US20120128656A1 (en)	2008-05-02	2012-05-24	Immunovative Therapies, Ltd.	Vaccine compositions and methods
US9695397B2 (en)	2008-10-01	2017-07-04	Immunovative Therapies Ltd.	Th1 vaccination priming for active immunotherapy
PT2606125T (pt) *	2010-08-20	2018-02-27	Immunovative Therapies Ltd	Células que expressam características th1 e propriedades citolíticas
KR102202460B1 (ko)	2011-05-03	2021-01-14	이뮤노베이티브 테라피스, 엘티디.	생세포를 포함하는 생물학적 약물을 처리하기 위한 방법
PH12013502252B1 (en)	2011-05-03	2018-09-21	Immunovative Therapies Ltd	Induction of il-12 using immunotherapy
SG10201705494YA (en)	2013-06-24	2017-08-30	Wolf Wilson Mfg Corp	Closed system device and methods for gas permeable cell culture process
CN103525763A (zh) *	2013-09-28	2014-01-22	青岛麦迪赛斯生物科技有限公司	一种高效cik细胞的培养方法
WO2015105999A1 (en) *	2014-01-08	2015-07-16	Immunovative Therapies, Ltd.	Treatment of human immunodeficiency virus/acquired immunodeficiency syndrome
US11466253B2 (en)	2015-10-22	2022-10-11	Juno Therapeutics Gmbh	Methods for culturing cells and kits and apparatus for same
WO2017106453A1 (en) *	2015-12-17	2017-06-22	University Of Maryland, Baltimore County	A recombinant bi-specific polypeptide for coordinately activating tumor-reactive t-cells and neutralizing immune suppression
CN109196094A (zh) *	2016-03-17	2019-01-11	伯克利之光生命科技公司	微流体装置中t淋巴细胞的选择和克隆
SG11201809805WA (en)	2016-05-05	2018-12-28	Southwest Res Inst	Three-dimensional bioreactor for cell expansion and related applications
US10294454B2 (en)	2016-08-24	2019-05-21	General Electric Company	Methods and kits for cell activation
US11149244B2 (en)	2018-04-04	2021-10-19	Southwest Research Institute	Three-dimensional bioreactor for T-cell activation and expansion for immunotherapy
SG11202102986XA (en)	2018-09-24	2021-04-29	Southwest Res Inst	Three-dimensional bioreactors
AU2022377625B2 (en)	2021-10-28	2025-01-02	Southwest Research Institute	Devices for cell separation

Family Cites Families (51)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2439003A1 (fr)	1978-10-20	1980-05-16	Anvar	Nouvelles pieces d'osteosynthese, leur preparation et leur application
US4279248A (en) *	1979-07-20	1981-07-21	Shlomo Gabbay	Sternum closure device and procedure for using same
US5766920A (en)	1982-08-11	1998-06-16	Cellcor, Inc.	Ex vivo activation of immune cells
WO1988000970A2 (en)	1986-08-08	1988-02-11	Regents Of The University Of Minnesota	Method of culturing leukocytes
AU2635088A (en)	1987-12-04	1989-06-08	Du Pont Merck Pharmaceutical Company, The	Immobilized interleukin 2 and interleukin 2 containing a carboxyl-terminal extension
US6905680B2 (en)	1988-11-23	2005-06-14	Genetics Institute, Inc.	Methods of treating HIV infected subjects
US6352694B1 (en) *	1994-06-03	2002-03-05	Genetics Institute, Inc.	Methods for inducing a population of T cells to proliferate using agents which recognize TCR/CD3 and ligands which stimulate an accessory molecule on the surface of the T cells
CA2003455C (en) *	1988-11-23	2000-02-22	Craig B. Thompson	Immunotherapy involving cd28 stimulation
US6534055B1 (en) *	1988-11-23	2003-03-18	Genetics Institute, Inc.	Methods for selectively stimulating proliferation of T cells
WO1993019767A1 (en) *	1992-04-07	1993-10-14	The Regents Of The University Of Michigan	Cd28 pathway immunoregulation
US5126132A (en)	1989-08-21	1992-06-30	The United States Of America As Represented By The Department Of Health And Human Services	Tumor infiltrating lymphocytes as a treatment modality for human cancer
US5728388A (en)	1989-10-03	1998-03-17	Terman; David S.	Method of cancer treatment
CA2065658A1 (en) *	1991-04-19	1992-10-20	Tse-Wen Chang	Conjugates of liposomes or microbeads and antibodies specific for t lymphocytes and their use in vivo immune modulators
JP3355666B2 (ja) *	1992-10-22	2002-12-09	ソニー株式会社	変調回路
WO1994012196A1 (en)	1992-11-25	1994-06-09	Tanox Biosystems, Inc.	Conjugates and constructs including anti-cd28 and anti-cd3 binding molecules
WO1994029436A1 (en) *	1993-06-04	1994-12-22	The United States Of America Represented By The Secretary Of The Navy	Methods for selectively stimulating proliferation of t cells
EP0726941B1 (en)	1993-08-06	2002-04-03	Epimmune Inc.	Methods for (ex vivo) therapy using peptide-loaded antigen presenting cells for the activation of ctl
IL107483A0 (en) *	1993-11-03	1994-02-27	Yeda Res & Dev	Bone marrow transplantation
CA2191586A1 (en) *	1994-06-03	1995-12-14	Carl H. June	Methods for selectively stimulating proliferation of t cells
US5827642A (en)	1994-08-31	1998-10-27	Fred Hutchinson Cancer Research Center	Rapid expansion method ("REM") for in vitro propagation of T lymphocytes
EP0814838B1 (en)	1995-03-08	2003-05-14	The Scripps Research Institute	Antigen presenting system and activation of t-cells
DE19545257A1 (de) *	1995-11-24	1997-06-19	Schering Ag	Verfahren zur Herstellung von morphologisch einheitlichen Mikrokapseln sowie nach diesem Verfahren hergestellte Mikrokapseln
JP2002516562A (ja)	1996-03-04	2002-06-04	ターゲティッドジェネティックスコーポレイション	Ｔリンパ球のインビトロ増殖のための改変された迅速な拡大方法（「改変ｒｅｍ」）
AU723355B2 (en)	1996-05-23	2000-08-24	Scripps Research Institute, The	MHC class II antigen presenting systems and methods for activating CD4+ T cells
DE69732721T2 (de) *	1996-12-03	2006-05-18	Osteobiologics, Inc., San Antonio	Biologisch abbaubare kunstoff-folien
JP2002515756A (ja)	1997-01-31	2002-05-28	ヘモソルインク．	選択されたリンパ球の生産方法
CA2291718A1 (en) *	1997-05-30	1998-12-03	Osteobiologics, Inc.	Fiber-reinforced, porous, biodegradable implant device
CA2309206A1 (en)	1997-11-10	1999-05-20	Arch Development Corporation	Methods for treatment of tumors and tumor cells using ex vivo activated t cells
CA2360019A1 (en) *	1999-01-29	2000-08-03	Shixin Qin	Anti-ccr1 antibodies and methods of use therefor
JP2001054563A (ja) *	1999-07-12	2001-02-27	Isotis Bv	縫合糸
DE60130538T2 (de) *	2000-02-03	2008-06-12	Millenium Pharmaceuticals, Inc., Cambridge	Humanisierte antikörper gegen ccr2 und verfahren zur deren verwendung
AU2001243145A1 (en) *	2000-02-09	2001-08-20	Human Genome Sciences, Inc.	Human g-protein chemokine receptor (ccr5) hdgnr10
US20030119185A1 (en) *	2000-02-24	2003-06-26	Xcyte Therapies, Inc.	Activation and expansion of cells
US6867041B2 (en) *	2000-02-24	2005-03-15	Xcyte Therapies, Inc.	Simultaneous stimulation and concentration of cells
BR0108545A (pt) *	2000-02-24	2004-06-29	Xcyte Therapies Inc	Estimulação e concentração simultâneas das células
WO2002017935A2 (en) *	2000-08-31	2002-03-07	Emory University	A method of transplantation using chemotherapy-treated allogeneic cells that enhance immune responses without graft versus host disease
US6626950B2 (en) *	2001-06-28	2003-09-30	Ethicon, Inc.	Composite scaffold with post anchor for the repair and regeneration of tissue
US20040258661A1 (en)	2001-10-31	2004-12-23	Daniel Fowler	Generation of use of tc1 and tc2 cells
US7105580B2 (en) *	2001-12-06	2006-09-12	University Of Washington	Porous structures useful for growing living tissue, and methods of manufacture
AU2003202908A1 (en) *	2002-01-03	2003-07-24	The Trustees Of The University Of Pennsylvania	Activation and expansion of t-cells using an engineered multivalent signaling platform
US20030175272A1 (en) *	2002-03-07	2003-09-18	Medcell Biologics, Inc.	Re-activated T-cells for adoptive immunotherapy
DE10230223A1 (de)	2002-07-04	2004-01-22	Tegenero Ag	Mikropartikel mit CD28-spezifischen monoklonalen Antikörpern
CA2493081C (en)	2002-07-12	2013-04-23	The Johns Hopkins University	Reagents and methods for engaging unique clonotypic lymphocyte receptors
US7402431B2 (en) *	2004-03-01	2008-07-22	Immunovative Therapies, Ltd.	T-cell therapy formulation
US7435592B2 (en) *	2003-05-13	2008-10-14	Immunovative Therapies, Ltd.	Compositions for allogeneic cell therapy
US7371228B2 (en) *	2003-09-19	2008-05-13	Medtronic Vascular, Inc.	Delivery of therapeutics to treat aneurysms
SI2573166T1 (sl) *	2004-02-26	2016-09-30	Immunovative Therapies, Ltd.	Metode za pripravo T-celic za celično terapijo
US7592431B2 (en) *	2004-02-26	2009-09-22	Immunovative Therapies, Ltd.	Biodegradable T-cell Activation device
US7446099B2 (en) *	2004-02-27	2008-11-04	Nitto Denko Corporation	Compositions and methods for biodegradable polymer-peptide mediated transfection
CA2530514C (en)	2004-03-01	2017-01-31	Immunovative Therapies, Ltd.	Cell therapy formulation method and composition
WO2005089127A2 (en) *	2004-03-05	2005-09-29	The Trustees Of Columbia University In The City Of New York	Polymer-ceramic-hydrogel composite scaffold for osteochondral repair

2005
- 2005-02-24 SI SI200532071A patent/SI2573166T1/sl unknown
- 2005-02-24 LT LTEP12177732.0T patent/LT2573166T/lt unknown
- 2005-02-24 JP JP2007500948A patent/JP2007525225A/ja not_active Withdrawn
- 2005-02-24 PL PL12177732.0T patent/PL2573166T3/pl unknown
- 2005-02-24 EP EP16161764.2A patent/EP3067415A1/en not_active Ceased
- 2005-02-24 CA CA2555714A patent/CA2555714C/en not_active Expired - Lifetime
- 2005-02-24 PT PT121777320T patent/PT2573166T/pt unknown
- 2005-02-24 ES ES12177732.0T patent/ES2586295T3/es not_active Expired - Lifetime
- 2005-02-24 WO PCT/US2005/005775 patent/WO2005081982A2/en not_active Ceased
- 2005-02-24 US US11/066,133 patent/US7678572B2/en not_active Expired - Lifetime
- 2005-02-24 HU HUE12177732A patent/HUE028467T2/en unknown
- 2005-02-24 EP EP12177732.0A patent/EP2573166B1/en not_active Expired - Lifetime
- 2005-02-24 DK DK12177732.0T patent/DK2573166T3/da active
- 2005-02-24 EP EP05713988A patent/EP1776583A4/en not_active Ceased
2006
- 2006-08-10 IL IL177404A patent/IL177404A/en active IP Right Revival
2010
- 2010-01-14 US US12/687,281 patent/US7956164B2/en not_active Expired - Lifetime
- 2010-06-17 US US12/817,512 patent/US8071374B2/en not_active Expired - Lifetime
- 2010-12-28 JP JP2010294225A patent/JP2011072319A/ja not_active Withdrawn
2011
- 2011-03-31 US US13/077,347 patent/US8883974B2/en not_active Expired - Lifetime
- 2011-07-21 US US13/187,991 patent/US8313944B2/en not_active Expired - Fee Related
2013
- 2013-11-22 JP JP2013241607A patent/JP6031021B2/ja not_active Expired - Lifetime
2014
- 2014-09-29 US US14/500,381 patent/US9593308B2/en not_active Expired - Fee Related
2015
- 2015-03-31 JP JP2015071186A patent/JP2015129184A/ja not_active Withdrawn
2016
- 2016-06-17 CY CY20161100547T patent/CY1117750T1/el unknown
2017
- 2017-02-17 JP JP2017027483A patent/JP2017093468A/ja not_active Withdrawn

Also Published As

Publication number	Publication date
JP2014042529A (ja)	2014-03-13
EP2573166A2 (en)	2013-03-27
CA2555714C (en)	2013-12-03
US20150024489A1 (en)	2015-01-22
EP1776583A2 (en)	2007-04-25
JP2007525225A (ja)	2007-09-06
WO2005081982A2 (en)	2005-09-09
JP6031021B2 (ja)	2016-11-24
LT2573166T (lt)	2016-09-26
EP2573166B1 (en)	2016-05-11
WO2005081982A3 (en)	2007-01-25
HUE028467T2 (en)	2016-12-28
JP2011072319A (ja)	2011-04-14
US9593308B2 (en)	2017-03-14
IL177404A (en)	2016-12-29
PT2573166T (pt)	2016-07-07
CY1117750T1 (el)	2017-05-17
US8071374B2 (en)	2011-12-06
PL2573166T3 (pl)	2016-11-30
EP3067415A1 (en)	2016-09-14
US20100255043A1 (en)	2010-10-07
ES2586295T3 (es)	2016-10-13
US7956164B2 (en)	2011-06-07
JP2017093468A (ja)	2017-06-01
EP2573166A3 (en)	2013-05-29
US7678572B2 (en)	2010-03-16
US20110281357A1 (en)	2011-11-17
US20100113753A1 (en)	2010-05-06
US8883974B2 (en)	2014-11-11
SI2573166T1 (sl)	2016-09-30
US20110177596A1 (en)	2011-07-21
US8313944B2 (en)	2012-11-20
EP1776583A4 (en)	2009-04-29
US20050191291A1 (en)	2005-09-01
JP2015129184A (ja)	2015-07-16
IL177404A0 (en)	2007-07-04
CA2555714A1 (en)	2005-09-09

Publication	Publication Date	Title
DK1638750T3 (da)	2012-11-26	Fremgangsmåder til fremstilling af gelplader
DK1941026T3 (da)	2014-07-21	Fremgangsmåder til fremstilling af protein under anvendelse af anti-senescensforbindelser
DK1748077T3 (da)	2013-04-08	Fremgangsmåde til fremstilling af protein
DE602005026106D1 (de)	2011-03-10	Brennstoffzellensystem
DE112005003074B8 (de)	2023-07-27	Brennstoffzellensystem
DK2959774T3 (da)	2019-05-13	Fremgangsmåde til kryokonservering af sædceller
DE602004007616D1 (de)	2007-08-30	Asynchrone unterstützte GPS-Positionsbestimmung
DK1852430T3 (da)	2019-08-05	Fremgangsmåde til fremstilling af proanthocyanidinoligomer
LT2573166T (lt)	2016-09-26	T ląstelių paruošimo būdas ląstelių terapijai
DE602005003581D1 (de)	2008-01-10	Elektrolysezelle
DE602005020481D1 (de)	2010-05-20	Brennstoffzellensystem
DK1926582T3 (da)	2012-08-20	Fremgangsmåder til beredning af læder
DE602005019478D1 (de)	2010-04-01	Brennstoffzellensystem
DE602005017745D1 (de)	2009-12-31	Brennstoffzellen-auseinanderbauverfahren
DE602005020227D1 (de)	2010-05-12	Brennstoffzellensystem
NO20044109L (no)	2005-12-19	Stromskinne-holdeanordning
FI20040970A0 (fi)	2004-07-09	Laitteisto solujen kuvaamiseksi
DE602005000791D1 (de)	2007-05-16	Zwischenverbinder
DE602005025931D1 (de)	2011-02-24	Brennstoffzelle
IS8570A (is)	2006-11-20	Stoðfrumulaus framhaldsrækt stofnfrumna
EP1766389A4 (en)	2008-08-27	METHOD OF ISOLATING CELLS
DE602005023645D1 (de)	2010-10-28	Brennstoffzellenseparator
EP1784883A4 (en)	2009-09-16	FUEL CELL SYSTEM
DE602005026944D1 (de)	2011-04-28	Brennstoffzelle
DK1864987T3 (da)	2010-04-12	Fremgangsmåder til fremstilling af 3-O-beskyttede morphinoner og 3-O-beskyttede morphinon-dienol-carboxylater